Portolan Capital Management’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $2.82M | Sell |
|
|||||
|
2023
Q1 | $6.18M | Buy |
|
|||||
|
2022
Q4 | $6.15M | Sell |
|
|||||
|
2022
Q3 | $5.58M | Sell |
|
|||||
|
2022
Q2 | $5.27M | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $2.17M | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $273K | Sell |
|
|||||
|
2020
Q2 | $370K | Sell |
|
|||||
|
2020
Q1 | $319K | Sell |
|
|||||
|
2019
Q4 | $750K | Hold |
|
|||||
|
2019
Q3 | $794K | Sell |
|
|||||
|
2019
Q2 | $627K | Buy |
|
|||||
|
2019
Q1 | $443K | Sell |
|
|||||
|
2018
Q4 | $3.98M | Sell |
|
|||||
|
2018
Q3 | $5.54M | Sell |
|
|||||
|
2018
Q2 | $5.19M | Buy |
|
|||||
|
2018
Q1 | $2.88M | Buy |
|
|||||
|
2017
Q4 | $785K | Sell |
|
|||||
|
2017
Q3 | $845K | Hold |
|
|||||
|
2017
Q2 | $719K | Sell |
|
|||||
|
2017
Q1 | $643K | Sell |
|
|||||
|
2016
Q4 | $3.32M | Buy |
|
|||||
|
2016
Q3 | $3.12M | Buy |
|
|||||
|
2016
Q2 | $2.77M | Sell |
|
|||||
|
2016
Q1 | $5.86M | Sell |
|
|||||
|
2015
Q4 | $18.6M | Sell |
|
|||||
|
2015
Q3 | $20.3M | Buy |
|
|||||
|
2015
Q2 | $16.3M | Buy |
|
|||||
|
2015
Q1 | $15M | Buy |
|
|||||
|
2014
Q4 | $12.6M | Buy |
|
|||||
|
2014
Q3 | $9.27M | Buy |
|
|||||
|
2014
Q2 | $10.1M | Buy |
|
|||||
|
2014
Q1 | $7.23M | Buy |
|
|||||
|
2013
Q4 | $5.07M | Sell |
|
|||||
|
2013
Q3 | $3.44M | Sell |
|
|||||
|
2013
Q2 | $3.13M | Buy |
|